QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
NASDAQ:APLS

Apellis Pharmaceuticals - APLS Insider Trading & Ownership

$64.98
-0.68 (-1.04%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$64.83
$66.22
50-Day Range
$50.49
$66.96
52-Week Range
$33.32
$70.75
Volume
808,204 shs
Average Volume
1.69 million shs
Market Capitalization
$7.23 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$78.40

Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.00%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
12
Amount Of
Insider Selling
(Last 12 Months)
$21.11 M

APLS Insider Buying and Selling by Quarter

Get APLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Apellis Pharmaceuticals Insider Trades History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/21/2023Cedric FrancoisCEOSell30,000$62.74$1,882,200.001,144,591  
3/17/2023Alec MachielsDirectorSell1,250$64.03$80,037.50267,641  
3/8/2023Pascal DeschateletsInsiderSell12,000$63.79$765,480.001,020,813  
2/23/2023Jeffrey EiseleInsiderSell1,646$68.76$113,178.9653,883  
2/8/2023Pascal DeschateletsInsiderSell12,000$54.45$653,400.001,006,756  
2/3/2023Adam J TownsendInsiderSell5,000$55.85$279,250.0067,932  
1/30/2023Jeffrey EiseleInsiderSell883$52.76$46,587.0846,468  
1/23/2023Karen LewisInsiderSell2,955$51.58$152,418.9037,709  
1/17/2023Alec MachielsDirectorSell1,250$52.42$65,525.00267,641  
1/9/2023Pascal DeschateletsInsiderSell12,000$46.08$552,960.00983,780  
1/5/2023Federico GrossiInsiderSell2,500$48.79$121,975.0094,884  
1/3/2023A. Sinclair DunlopDirectorSell500$50.70$25,350.00132,797  
1/3/2023Adam J TownsendInsiderSell5,000$50.70$253,500.0042,907  
12/19/2022Cedric FrancoisCEOSell28,200$52.06$1,468,092.00965,128  
12/15/2022Alec MachielsDirectorSell1,250$52.35$65,437.50263,774  
12/8/2022Pascal DeschateletsInsiderSell12,000$47.50$570,000.00970,280  
12/5/2022Adam J TownsendInsiderSell5,000$50.38$251,900.0042,907  
12/1/2022A. Sinclair DunlopDirectorSell500$49.93$24,965.00129,430  
12/1/2022Federico GrossiInsiderSell2,500$49.93$124,825.0097,384  
11/8/2022Pascal DeschateletsInsiderSell12,000$46.47$557,640.00963,780  
11/3/2022Adam J TownsendInsiderSell5,000$58.54$292,700.0042,907  
10/14/2022Alec MachielsDirectorSell1,250$59.31$74,137.50263,774  
10/10/2022Pascal DeschateletsInsiderSell12,000$57.50$690,000.00957,280  
10/3/2022Federico GrossiInsiderSell2,500$66.69$166,725.00102,384  
9/15/2022Alec MachielsDirectorSell1,250$66.00$82,500.00263,774  
9/8/2022Pascal DeschateletsInsiderSell12,000$63.98$767,760.00950,780  
8/17/2022Mark Jeffrey DelongSVPSell5,000$69.50$347,500.0029,250  
8/15/2022Adam J TownsendInsiderSell12,500$69.00$862,500.0042,907  
8/15/2022Alec MachielsDirectorSell1,250$67.21$84,012.50263,774  
8/11/2022A. Sinclair DunlopDirectorSell30,000$65.63$1,968,900.00255,679  
8/11/2022Adam J TownsendInsiderSell12,500$67.00$837,500.0042,907  
8/11/2022Mark Jeffrey DelongSVPSell5,000$67.00$335,000.0029,250  
8/3/2022Adam J TownsendInsiderSell5,000$56.43$282,150.0037,907  
8/1/2022Federico GrossiInsiderSell2,500$55.99$139,975.00107,384  
7/27/2022Mark Jeffrey DelongSVPSell5,000$57.00$285,000.0029,250  
7/19/2022Mark Jeffrey DelongSVPSell5,000$56.42$282,100.0029,250  
7/15/2022Alec MachielsDirectorSell1,250$46.33$57,912.50263,774  
7/11/2022Adam J TownsendInsiderSell5,000$48.42$242,100.0042,907  
7/8/2022Pascal DeschateletsInsiderSell12,000$47.95$575,400.00937,780  
6/27/2022A. Sinclair DunlopDirectorSell1,341$46.79$62,745.391,341  
6/23/2022A. Sinclair DunlopDirectorSell15,000$45.00$675,000.00285,679  
6/22/2022David O WatsonGeneral CounselSell10,000$44.51$445,100.00115,569  
6/17/2022Victoria L BrownInsiderSell2,698$45.00$121,410.0024,974  
6/16/2022Mark Jeffrey DelongSVPSell10,000$41.78$417,800.0029,250  
6/15/2022Alec MachielsDirectorSell1,250$39.29$49,112.50263,774  
6/8/2022Pascal DeschateletsInsiderSell12,000$44.09$529,080.00891,775  
6/1/2022Federico GrossiInsiderSell2,500$41.78$104,450.00109,561  
5/27/2022Lukas ScheiblerInsiderSell10,000$43.00$430,000.0040,358  
5/16/2022Alec MachielsDirectorSell1,250$39.18$48,975.00263,774  
5/2/2022Federico GrossiInsiderSell2,500$43.56$108,900.00112,061  
4/29/2022Pascal DeschateletsInsiderSell4,000$44.43$177,720.00891,775  
4/25/2022David O WatsonGeneral CounselSell5,000$50.00$250,000.00125,569  
4/20/2022Mark Jeffrey DelongSVPSell7,000$52.53$367,710.0028,481  
4/14/2022Alec MachielsDirectorSell1,250$50.90$63,625.00263,774  
4/4/2022Lukas ScheiblerInsiderSell3,504$56.96$199,587.8452,233  
4/1/2022Lukas ScheiblerInsiderSell11,496$55.05$632,854.8052,233  
(Data available from 1/1/2013 forward)












APLS Insider Trading Activity - Frequently Asked Questions

Who is on Apellis Pharmaceuticals's Insider Roster?

The list of insiders at Apellis Pharmaceuticals includes A. Sinclair Dunlop, Adam J Townsend, Alec Machiels, Cedric Francois, David O Watson, Federico Grossi, Jeffrey Eisele, Karen Lewis, Lukas Scheibler, Mark Jeffrey Delong, Morningside Venture Investment, Nicole D Perry, Pascal Deschatelets, Victoria L Brown. Learn more on insiders at APLS.

What percentage of Apellis Pharmaceuticals stock is owned by insiders?

8.00% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings.

Which Apellis Pharmaceuticals insiders have been buying company stock?

The following insider purchased APLS shares in the last 24 months: Morningside Venture Investment ($10,000,000.00).

How much insider buying is happening at Apellis Pharmaceuticals?

Insiders have purchased a total of 250,000 APLS shares in the last 24 months for a total of $10,000,000.00 bought.

Which Apellis Pharmaceuticals insiders have been selling company stock?

The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($10,935,082.49), Adam J Townsend ($3,301,600.00), Alec Machiels ($1,260,450.00), Cedric Francois ($3,350,292.00), David O Watson ($1,258,699.51), Federico Grossi ($986,186.00), Jeffrey Eisele ($159,766.04), Karen Lewis ($152,418.90), Lukas Scheibler ($2,042,864.95), Mark Jeffrey Delong ($2,532,250.00), Nicole D Perry ($167,950.00), Pascal Deschatelets ($6,537,815.00), and Victoria L Brown ($121,410.00).

How much insider selling is happening at Apellis Pharmaceuticals?

Insiders have sold a total of 608,171 Apellis Pharmaceuticals shares in the last 24 months for a total of $32,806,784.89 sold.

This page (NASDAQ:APLS) was last updated on 3/28/2023 by MarketBeat.com Staff